SEZL:NASDAQSezzle Inc. Analysis
Data as of 2026-06-06 - not real-time
$116.01
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Sezzle Inc. (SEZL) is trading at $116.01, comfortably above its 20‑day SMA of 108.9 and the 50‑day SMA of 88.4, confirming a bullish price trend, yet the MACD shows a bearish crossover with a negative histogram and the RSI sits at 61, hinting at modest overbought pressure. Revenue surged 29.2% YoY to $135.5 million and GMV jumped 37.3%, driving a 41.9% rise in adjusted net income and an EPS of $5.10 that beat guidance, while the company lifted FY2026 revenue growth guidance to 30‑35%. The balance sheet reveals $120.4 million in cash against $145.2 million of debt, yielding a debt‑to‑equity of 73.8%, but the firm generates strong cash flow with $72.5 million free cash and a remarkable ROE of 92%. Valuation metrics are stretched: a trailing PE of 23.5 versus an industry average of 17, a PB of 19.8, and a DCF‑derived fair value of $77.2, placing the stock about 3.7% above fair value and classifying it as overvalued. Volatility is high at 71% over 30 days and beta is elevated at 2.39, reflecting sensitivity to market swings. Material news highlights robust earnings and upgraded guidance, but also flags a federal securities law investigation, adding regulatory uncertainty. Overall, the stock combines strong growth fundamentals with elevated valuation and risk factors, suggesting a nuanced outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD signal and high short‑term volatility
- Current price near but below resistance level
- Regulatory investigation could trigger price pressure
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Strong revenue and earnings growth with raised guidance
- High operating margins and robust cash generation
- Market positioning in fast‑growing buy‑now‑pay‑later segment
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustained high ROE and margin profile
- Elevated valuation multiples relative to peers
- Persistent regulatory and market‑sensitivity risks
Key Metrics & Analysis
Financial Health
Revenue Growth29.20%
Profit Margin30.83%
P/E Ratio23.5
ROE91.95%
ROA47.54%
Debt/Equity73.79
P/B Ratio19.8
Op. Cash Flow$246.4M
Free Cash Flow$72.5M
Industry P/E17.0
Technical Analysis
TrendBullish
RSI61.2
Support$91.74
Resistance$123.04
MA 20$108.91
MA 50$88.35
MA 200$76.32
MACDBearish
VolumeStable
Fear & Greed Index83.02
Valuation
Fair Value$77.19
Target Price$120.33
Upside/Downside3.73%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta2.39
Volatility71.21%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.